A Washington, D.C. federal appeals court today upheld HHS’ authority to require drugmakers to seek approval before implementing 340B rebate [...] …
Judicial
A major North Carolina health system on Friday appeared to settle two lawsuits alleging health insurer Humana underpaid for 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
Five major hospital and pharmacist groups on Tuesday urged a federal judge to reject drugmaker AbbVie’s lawsuit challenging HRSA’s longstanding [...] …
Please Login or Become a Paid Subscriber to View this Content
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
Two national 340B provider groups asked a federal judge Monday for permission to join HRSA in defending the agency’s 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
Philip Perry, a longtime pharmaceutical industry attorney who has represented PhRMA and drug manufacturers in major 340B litigation, officially retired [...] …
Please Login or Become a Paid Subscriber to View this Content
A Florida hospital recently sued Eli Lilly, alleging the pharmaceutical giant unlawfully cut off 340B pricing after the hospital refused [...] …
Please Login or Become a Paid Subscriber to View this Content
Four major drugmakers recently renewed their push to dismiss a California health system’s 340B overcharge whistleblower lawsuit—just months after a [...] …
Please Login or Become a Paid Subscriber to View this Content
A St. Louis federal appeals court on Wednesday rejected Swiss drugmaker Novartis’ bid to block Missouri’s 340B contract pharmacy access [...] …
Please Login or Become a Paid Subscriber to View this Content
A New York federal judge recently kept most of two health centers’ state 340B antitrust claims alive against four insulin [...] …